Clinical Trial Update: The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether carvedilol can prevent cardiac dysfunction in patients with Duchenne Muscular Dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Duchenne Muscular Dystrophy

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Suzuka Hospital | Conditions: Duchenne Muscular Dystrophy, Cardiomyopathies | Phase 4 | Status: UNKNOWN